Biomarkers Discovery and Novel Diagnostics

The group has to complementary research lines aiming at helping translating basic research to clinical practice.

1) Finding new biomarkers with clinical relevance, using proteomic approaches;

2) R&D of electrochemical biosensors for point-of-care testing of clinical metabolites, such as cardiovascular biomarkers.

 

 

 

Member of:

                             CiiEM

www.egasmoniz.com.pt/pt-pt/ciiem.aspx

www.egasmoniz.com.pt/pt-pt.aspx

                                                                        

                                                                        UCIBIO@REQUIMTE

                                                                      

                                                                 www.requimte.pt/ucibio/

News

1 | 2 >>

© 2015 Todos os direitos reservados.

Crie o seu site grátisWebnode